Retinal function in carriers of Bardet-Biedl syndrome
- PMID: 12796250
- DOI: 10.1001/archopht.121.6.804
Retinal function in carriers of Bardet-Biedl syndrome
Abstract
Objective: To test the hypothesis that carriers of Bardet-Biedl syndrome have abnormal rod-mediated responses.
Methods: Parents (n = 26) of children with Bardet-Biedl syndrome (BBS), who are obligate carriers of BBS, consented to scotopic, full-field electroretinography (ERG). Responses were recorded over a 4 to 5 log unit range, up to a maximum stimulus of approximately +3.6 log scotopic troland seconds. The parameters of activation of the rod photoresponse, S (sensitivity parameter) and Rmp3(amplitude of the saturated rod response), were derived by fitting a transduction model to the ERG a-waves. For the b-wave, the stimulus producing a half maximum response (log sigma) and the saturated amplitude (Vmax) were determined. The model of the rod photoresponse was subtracted from the intact ERG to demonstrate a corneal positive potential (P2), and log kP2 and P2max were determined. The carriers' ERG responses were compared with those of healthy control subjects (n = 26).
Main outcome measures: Sensitivity (S, log sigma, and log kP2) and saturated amplitude (Rmp3, Vmax, and P2max) of receptoral and postreceptoral response components.
Results: All parents had decreased P2 sensitivity, and most (15 [60%] of 26) had decreased b-wave sensitivity. The rod photoresponse sensitivity and the saturated amplitudes of the rod cell response, b-wave and P2, did not differ significantly between carriers and controls.
Conclusions: Diminished P2 sensitivity is characteristic of the carriers of BBS. The site of the primary defect in the BBS rod pathway appears to be proximal to the outer segments, most likely before the rod-bipolar cell synapse.
Similar articles
-
Retinal dysfunction in carriers of bardet-biedl syndrome.Ophthalmic Genet. 2007 Sep;28(3):163-8. doi: 10.1080/13816810701537440. Ophthalmic Genet. 2007. PMID: 17896315
-
The development of scotopic sensitivity.Invest Ophthalmol Vis Sci. 2000 May;41(6):1588-96. Invest Ophthalmol Vis Sci. 2000. PMID: 10798680
-
Rod and rod mediated function in patients with beta-thalassemia major.Doc Ophthalmol. 1998-1999;96(4):333-45. doi: 10.1023/a:1001728512515. Doc Ophthalmol. 1998. PMID: 10855809
-
Beta wave of the scotopic (rod) electroretinogram as a measure of the activity of human on-bipolar cells.J Opt Soc Am A Opt Image Sci Vis. 1996 Mar;13(3):623-33. doi: 10.1364/josaa.13.000623. J Opt Soc Am A Opt Image Sci Vis. 1996. PMID: 8627419 Review.
-
Ciliopathy: Bardet-Biedl Syndrome.Adv Exp Med Biol. 2018;1085:171-174. doi: 10.1007/978-3-319-95046-4_33. Adv Exp Med Biol. 2018. PMID: 30578506 Review.
Cited by
-
Ablation of Mature miR-183 Leads to Retinal Dysfunction in Mice.Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):12. doi: 10.1167/iovs.61.3.12. Invest Ophthalmol Vis Sci. 2020. PMID: 32176259 Free PMC article.
-
Multifocal electroretinogram contributes to differentiation of various clinical pictures within a family with Bardet-Biedl syndrome.Eye (Lond). 2014 Sep;28(9):1136-42. doi: 10.1038/eye.2014.150. Epub 2014 Jul 4. Eye (Lond). 2014. PMID: 24993321 Free PMC article.
-
Preclinical dose response study shows NR2E3 can attenuate retinal degeneration in the retinitis pigmentosa mouse model RhoP23H+/.Gene Ther. 2024 May;31(5-6):255-262. doi: 10.1038/s41434-024-00440-6. Epub 2024 Jan 26. Gene Ther. 2024. PMID: 38273095 Free PMC article.
-
Family-based exome sequencing and case-control analysis implicate CEP41 as an ASD gene.Transl Psychiatry. 2019 Jan 15;9(1):4. doi: 10.1038/s41398-018-0343-z. Transl Psychiatry. 2019. PMID: 30664616 Free PMC article.
-
Bardet-Biedl Syndrome.Mol Syndromol. 2016 May;7(2):62-71. doi: 10.1159/000445491. Epub 2016 Apr 15. Mol Syndromol. 2016. PMID: 27385962 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources